WITHDRAWN: XB130 expression in human osteosarcoma: a clinical and experimental study

Xiaohui Wang,Ruiguo Wang,Zhaolong Liu,Linna Wang,Yu Li,Lin Zhang,Hai Huang,Wenchen Guo

DOI: https://doi.org/10.5414/CP202262

2015-05-22

Abstract:Ahead of Print article withdrawn by publisher.

What problem does this paper attempt to address?

[Retracted] MicroRNA‑505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion

Yu-Jiang Liu,Wei Li,Feng Chang,Jian-Na Liu,Jun-Xin Lin,De-Xi Chen

DOI: https://doi.org/10.3892/or.2023.8582

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the control GAPDH western blotting bands shown in Fig. 4H on p. 496 were strikingly similar to data that were submitted for publication in advance of this article in different form by different authors at different research institutes [Liu F, Bai C and Guo Z: The prognostic value of osteopontin in limited‑stage small cell lung cancer patients and its mechanism. Oncotarget 8: 70084‑70096, 2017]. A further independent investigation conducted in the Editorial Office revealed that other western blotting data were likely to have been shared in common, comparing between the two articles. Owing to the fact that the contentious data in the above article had already been submitted for publication prior to the submission of this article to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, it was admitted that the authors Feng Chang, Jian-Na Liu and Jun-Xin Lin did not initially provide their agreement to be authors on this paper; otherwise, the rest of the authors accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 39: 491‑500, 2018; DOI: 10.3892/or.2017.6142].
RETRACTED: Anti-proliferation and Anti-Metastatic Effects of Sevoflurane on Human Osteosarcoma U2OS and Saos-2 Cells.

Ke Gao,Zhen Su,Hailin Liu,Yan Liu

DOI: https://doi.org/10.1016/j.yexmp.2019.04.005

IF: 4.401

2019-01-01

Experimental and Molecular Pathology

Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).This article has been retracted at the request of the Editor-in-Chief and the authors. The journal was initially contacted by the corresponding author to request the retraction of the article as the results were reportedly not reproducible post-publication.Further investigation by the journal revealed also that the author name Hailin Liu was added to the authorship without editorial approval, after the article was accepted by the handling Editor. Other authorship issues as well as data realiability issues with the article were further revealed by the institutional investigation: http://med.china.com.cn/content/pid/291148/tid/1013/iswap/1.Given the concerns raised regarding panels from Figure 3A and also the comments of Dr Elisabeth Bik regarding this article “This paper belongs to a set of over 400 papers (as per February 2020) that share very similar Western blots with tadpole-like shaped bands, the same background pattern, and striking similarities in title structures, paper layout, bar graph design, and - in a subset - flow cytometry panels”, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article.
RETRACTION: Inhibition of microRNA-940 suppresses the migration and invasion of human osteosarcoma cells through the secreted frizzled-related protein 1-mediated Wnt/-catenin signaling pathway (Retraction of Vol 120, Pg 2657, 2019)

Zun-Wen Lin,Wei Zhang,Si-Ding Jiang,Wen-Bo Wei,Xiao-Feng Li

DOI: https://doi.org/10.1002/jcb.30102

2021-01-01

Journal of Cellular Biochemistry

Abstract:Retraction: "Inhibition of microRNA-940 suppresses the migration and invasion of human osteosarcoma cells through the secreted frizzled-related protein 1-mediated Wnt/beta-catenin signaling pathway," by Zun-Wen Lin, Wei Zhang, Si-Ding Jiang, Wen-Bo Wei, Xiao-Feng Li, J Cell Biochem. 2019; 2657-2670: The above article, published online on 15 October 2018 in Wiley Online Library () has been retracted by agreement between the journal's Editor in Chief, Prof. Dr. Christian Behl, and Wiley Periodicals LLC. The retraction has been agreed following an investigation based on allegations raised by a third party. A detailed investigation revealed that several image elements of the experimental data were published elsewhere in a different scientific context. Thus, the editors consider the conclusions of this article to be invalid.
[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

Jinfeng Han,Zhongmin Liu,Nanya Wang,Weiyun Pan

DOI: https://doi.org/10.3892/or.2022.8280

2022-01-01

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the western blotting data shown in Fig. 5D were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published on Oncology Reports 36: 542‑550, 2016; DOI: 10.3892/or.2016.4810].
[Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4

Yulong Liu,Ye Li,Jingchen Liu,Yuntao Wu,Qingsan Zhu

DOI: https://doi.org/10.3892/ijo.2023.5537

2023-01-01

International Journal of Oncology

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the flow cytometric data shown in Fig. 2D on p. 1675 had already been submitted in different form in the following paper written by different authors at different research institutes: Tian R, Li Y and Gao M: Shikonin causes cell‑cycle arrest and induces apoptosis by regulating the EGFR‑NF‑κB signalling pathway in human epidermoid carcinoma A431 cells. Biosci Rep 28: e00189, 2015. After having conducted an independent review of the data in this figure in the Editorial Office, the concerns of the reader were found to be validated. Therefore, since the contentious data in the above article had already been submitted for publication prior to its submission to International Journal of Oncology, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive any reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Oncology 47: 1672‑1684, 2015; DOI: 10.3892/ijo.2015.3147].
RETRACTED: ORIENT-3: A Randomized, Open-Label, Phase III Study of Sintilimab Versus Docetaxel in Previously Treated Advanced/metastatic Squamous Non-Small Cell Lung Cancer (Sqnsclc)

Yuan Shi,Lin Wu,Xinmin Yu,Puyuan Xing,Jianying Zhou,A. Wang,J. Shi,Yi Hu,Z. Wang,Gary An,Yiman Fang,Shuai Sun,Caicun Zhou,C. Wang,F. Ye,X. Li,J. Wang,M. Wang,Y. Liu,Yanqiu Zhao

DOI: https://doi.org/10.1016/j.annonc.2020.10.517

IF: 51.769

2020-01-01

Annals of Oncology

Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article was retracted at the request of the authors. The authors of this abstract have advised that full agreement between authors and sponsors on publication of the abstract has not been reached and they are therefore unable to publish this data at present.
[Retracted] miR‐17‐5p promotes the growth of osteosarcoma in a BRCC2‐dependent mechanism

Wei Wang,Liang Zhang,Ke Zheng,Xiaojing Zhang

DOI: https://doi.org/10.3892/or.2024.8710

2024-01-31

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the western blotting data shown in Fig. 7 on p. 1480 were strikingly similar to data that had already been published in another article written by different authors at different research institutes, which has subsequently been retracted [Fan C, Wang Y, Liu Z, Sun Y, Wang X, Wei G and Wei J: Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer. Int J Mol Med 36: 204‐214, 2015]. Owing to the fact that the contentious data in the above article were already under consideration for publication prior to its submission to Oncology Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 35: 1473‐1482, 2016; DOI: 10.3892/or.2016.4542]

oncology
[Retracted] Ursolic Acid Suppresses the Biological Function of Osteosarcoma Cells

Yi Pei,Yueyan Zhang,Ke Zheng,Guanning Shang,Yuming Wang,Wei Wang,Enduo Qiu,Xiaojing Zhang

DOI: https://doi.org/10.3892/ol.2023.13901

2023-01-01

Oncology Letters

Abstract:Following the publication of this paper, it was drawn to the Editor’s attention by a concerned reader that the β‑actin western blotting data featured in Fig. 4F on p. 2635 had already been published in another article written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Letters, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Letters 18: 2628‑2638, 2019; DOI: 10.3892/ol.2019.10561]
Retraction Note To: Effect of RAB31 Silencing on Osteosarcoma Cell Proliferation and Migration Through the Hedgehog Signaling Pathway

Qiong Yu,Dong Li,Dan Wang,Chun‑Mei Hu,Yan Sun,Yan Tang,Guang Shi

DOI: https://doi.org/10.1007/s00774-022-01316-8

2022-01-01

Journal of Bone and Mineral Metabolism

Abstract:The authors have retracted this article. After publication the authors discovered that they were unable to repeat their results. In this article the authors concluded that silencing the rab31 gene inhibits hedgehog pathway activation, but in the repeated experiments the authors found that the Hedgehog pathway was not activated when the rab31 gene was over-expressed.
Retraction Notice to “30MO ORIENT-3: A Randomized, Open-Label, Phase III Study of Sintilimab Versus Docetaxel in Previously Treated Advanced/metastatic Squamous Non-Small Cell Lung Cancer (Sqnsclc)”

Yuan Shi,Lin Wu,Xin Yu,Puyuan Xing,Jianying Zhou,A. Wang,Jiyun Shi,Yi Hu,Z. Wang,Gary An,Yong Fang,Shuai Sun,C. Zhou,C. Wang,Feina Ye,X Li,J. Wang,M Wang,Yang Liu,Yanqiu Zhao

DOI: https://doi.org/10.1016/j.annonc.2021.01.009

IF: 51.769

2021-01-01

Annals of Oncology

Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article was retracted at the request of the authors. The authors of this abstract have advised that full agreement between authors and sponsors on publication of the abstract has not been reached and they are therefore unable to publish this data at present.
[Retracted] Upregulation of Microrna‑25‑3p Inhibits Proliferation, Migration and Invasion of Osteosarcoma Cells in Vitro by Directly Targeting SOX4.

Xiaolin Wu,Hongzhong Zhou,Bin Yue,Maohua Li,Fengxia Liu,Chensheng Qiu,Bohua Chen,Xuexiao Ma

DOI: https://doi.org/10.3892/mmr.2022.12798

IF: 3.423

2022-01-01

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the cell migration assay data shown in Figs. 3B and 5C were strikingly similar to data that had appeared in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 16: 4293‑4300, 2017; DOI: 10.3892/mmr.2017.7103].
[Retracted] Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy

Zili Wang,Rongzhen He,Hansong Xia,Yu Wei,Song Wu

DOI: https://doi.org/10.3892/ol.2024.14466

2024-05-21

Oncology Letters

Abstract:Following the publication of this article, a concerned reader has drawn to the Editor's attention that the western blotting data featured in Figs. 2D, 3B, 5A and 5C contained some strikingly similar protein bands, such that these data apparently originated from the same original source where the results from differently performed experiments were intended to have been portrayed; moreover, the GAPDH control western blotting data shown in Fig. 1B were strikingly similar to data that had already appeared in a number of previous publications written by different authors at different research institutes. Owing to the identification of the apparently overlapping protein bands in Figs. 2, 3 and 5, and given the fact that the contentious data in Fig. 1B of the above article had already been published prior to its submission to Oncology Letters , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Letters 13: 3465‐3470, 2017; DOI: 10.3892/ol.2017.5941]

oncology
Statement of Retraction: TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation

DOI: https://doi.org/10.1080/15384101.2022.2046822

2022-03-18

Cell Cycle

Abstract:We, the Editors and Publisher of the journal Cell Cycle, have retracted the following article:

cell biology
Retracted: Increased EHHADH Expression Predicting Poor Survival of Osteosarcoma by Integrating Weighted Gene Coexpression Network Analysis and Experimental Validation

BioMed Research International

DOI: https://doi.org/10.1155/2024/9782859

2024-03-21

BioMed Research International

Abstract:This article has been retracted by Hindawi following an investigation undertaken by the publisher [1]. This investigation has uncovered evidence of one or more of the following indicators of systematic manipulation of the publication process: (1) Discrepancies in scope (2) Discrepancies in the description of the research reported (3) Discrepancies between the availability of data and the research described (4) Inappropriate citations (5) Incoherent, meaningless and/or irrelevant content included in the article (6) Manipulated or compromised peer review

biotechnology & applied microbiology,medicine, research & experimental
[Retracted] miR‐34a is downregulated in human osteosarcoma stem‐like cells and promotes invasion, tumorigenic ability and self‐renewal capacity

Yonggen Zou,Yuanshuai Huang,Jiexiang Yang,Jian Wu,Cheng Luo

DOI: https://doi.org/10.3892/mmr.2024.13196

IF: 3.423

2024-03-12

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell cell invasion assay data shown in Fig. 4B on p. 1635 were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes, which had either already been published or were submitted at around the same time. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 15: 1631‐1637, 2017; DOI: 10.3892/mmr.2017.6187]

oncology,medicine, research & experimental
MicroRNA-191-5p Promotes the Development of Osteosarcoma Via Targeting EGR1 and Activating the PI3K/AKT Signaling Pathway.

B Chen,Zhong Zheng,J-Z Yang,Li Xg

DOI: https://doi.org/10.26355/eurrev_202104_25706

2021-01-01

Abstract:The article "MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway, by B. Chen, Z.-Y. Zheng, J.-Z. Yang, X.-G. Li, published in Eur Rev Med Pharmacol Sci 2019; 23 (9): 3611-3620-DOI: 10.26355/eurrev_201905_17783-PMID: 31114985" has been withdrawn from the authors due to some disagreements over the drafting of the manuscript. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/17783.
Retracted: Interfering with pak4 Protein Expression Affects Osteosarcoma Cell Proliferation and Migration

BioMed Research International

DOI: https://doi.org/10.1155/2024/9849782

2024-03-20

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2021/9977001.].

biotechnology & applied microbiology,medicine, research & experimental
WITHDRAWN: MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.

Liwen Li,Xiangjun Sun,Xinran Wang,Chenhuan Ding

DOI: https://doi.org/10.1016/j.biopha.2014.12.018

2014-01-01

Abstract:This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
WITHDRAWN: ESM1-dependent mesenchymal transition enhances radioresistance of glioblastoma via transcriptional regulation of NFκB.

Jia Wang,Jie Zuo,Alafate Wahafu,Hai Yu,Wanfu Xie,Hua Zhang,Maode Wang

DOI: https://doi.org/10.1016/j.bbrc.2019.10.126

IF: 3.1

2019-01-01

Biochemical and Biophysical Research Communications

Abstract:This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
Microrna-336 Directly Targets Sox-2 in Osteosarcoma to Inhibit Tumorigenesis

Yong Cao,Tianding Wu,Dongzhe Li,Jianzhong Hu,Hongbin Lu

DOI: https://doi.org/10.3892/mmr.2017.6493

IF: 3.423

2017-01-01

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell cell migration and invasion assay data in Fig. 3C and D, and the tumour images shown in Fig. 4A were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes, which had already been published. In addition, certain of the data panels shown in Fig. 3C were overlapping, such that the data from the same original source had been selected to represent the results from allegedly differently performed experiments. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 15: 4217‑4224, 2017; DOI: 10.3892/mmr.2017.6493].

WITHDRAWN: XB130 expression in human osteosarcoma: a clinical and experimental study

[Retracted] MicroRNA‑505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion

RETRACTED: Anti-proliferation and Anti-Metastatic Effects of Sevoflurane on Human Osteosarcoma U2OS and Saos-2 Cells.

RETRACTION: Inhibition of microRNA-940 suppresses the migration and invasion of human osteosarcoma cells through the secreted frizzled-related protein 1-mediated Wnt/-catenin signaling pathway (Retraction of Vol 120, Pg 2657, 2019)

[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

[Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4

RETRACTED: ORIENT-3: A Randomized, Open-Label, Phase III Study of Sintilimab Versus Docetaxel in Previously Treated Advanced/metastatic Squamous Non-Small Cell Lung Cancer (Sqnsclc)

[Retracted] miR‐17‐5p promotes the growth of osteosarcoma in a BRCC2‐dependent mechanism

[Retracted] Ursolic Acid Suppresses the Biological Function of Osteosarcoma Cells

Retraction Note To: Effect of RAB31 Silencing on Osteosarcoma Cell Proliferation and Migration Through the Hedgehog Signaling Pathway

Retraction Notice to “30MO ORIENT-3: A Randomized, Open-Label, Phase III Study of Sintilimab Versus Docetaxel in Previously Treated Advanced/metastatic Squamous Non-Small Cell Lung Cancer (Sqnsclc)”

[Retracted] Upregulation of Microrna‑25‑3p Inhibits Proliferation, Migration and Invasion of Osteosarcoma Cells in Vitro by Directly Targeting SOX4.

[Retracted] Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy

Statement of Retraction: TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation

Retracted: Increased EHHADH Expression Predicting Poor Survival of Osteosarcoma by Integrating Weighted Gene Coexpression Network Analysis and Experimental Validation

[Retracted] miR‐34a is downregulated in human osteosarcoma stem‐like cells and promotes invasion, tumorigenic ability and self‐renewal capacity

MicroRNA-191-5p Promotes the Development of Osteosarcoma Via Targeting EGR1 and Activating the PI3K/AKT Signaling Pathway.

Retracted: Interfering with pak4 Protein Expression Affects Osteosarcoma Cell Proliferation and Migration

WITHDRAWN: MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.

WITHDRAWN: ESM1-dependent mesenchymal transition enhances radioresistance of glioblastoma via transcriptional regulation of NFκB.

Microrna-336 Directly Targets Sox-2 in Osteosarcoma to Inhibit Tumorigenesis